Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 7
Submit an article Journal homepage
5,631
Views
92
CrossRef citations to date
0
Altmetric
Original Research

Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy

Chunyan YueCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterial and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, P. R. China;Sino-Danish College, University of Chinese Academy of Sciences, Beijing, P. R. ChinaORCID Iconhttp://orcid.org/0000-0002-8045-5819 http://orcid.org/0000-0002-8045-5819 http://orcid.org/0000-0002-8045-5819View further author information
ORCID Icon ORCID Icon ORCID Icon,
Yubo JiangAffiliated Hospital Cancer Center, Academy of Military Medical Sciences, P. R. ChinaView further author information
,
Ping LiCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterial and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, P. R. ChinaView further author information
,
Yuehua WangCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterial and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, P. R. ChinaView further author information
,
Jian XueNanopep Biotech Co., Beijing, P. R. ChinaView further author information
,
Nannan LiNanopep Biotech Co., Beijing, P. R. ChinaView further author information
,
Da LiNanopep Biotech Co., Beijing, P. R. ChinaView further author information
,
Ruina WangKey Laboratory of Metabolism and Molecular Medicine, the Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, ShanghaiChina;Department of Pulmonary and Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, ChinaView further author information
,
Yongjun DangKey Laboratory of Metabolism and Molecular Medicine, the Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, ShanghaiChina;Department of Pulmonary and Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, ChinaView further author information
,
Zhiyuan HuCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterial and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, P. R. China;Sino-Danish College, University of Chinese Academy of Sciences, Beijing, P. R. China;Center for Neuroscience Research, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian Province, P. R. ChinaCorrespondence[email protected]
View further author information
,
Yanlian YangCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterial and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, P. R. China;Sino-Danish College, University of Chinese Academy of Sciences, Beijing, P. R. ChinaCorrespondence[email protected]
View further author information
&
Jianming XuAffiliated Hospital Cancer Center, Academy of Military Medical Sciences, P. R. ChinaCorrespondence[email protected]
View further author information
 show all
Article: e1438111 | Received 02 Jan 2018, Accepted 02 Feb 2018, Published online: 06 Mar 2018

Citations (92)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Zitao Liu, Huakai Tian & Zhengming Zhu. (2023) Application of Circulating Tumor Cells and Interleukin-6 in Preoperative Prediction of Peritoneal Metastasis of Advanced Gastric Cancer. Journal of Inflammation Research 16, pages 3033-3047.
Read now
Defeng Kong, Wen Zhang, Zhenrong Yang, Guoliang Li, Shujun Cheng, Kaitai Zhang & Lin Feng. (2021) Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysis. OncoImmunology 10:1.
Read now
Alessandro Russo, Diego De Miguel Perez, Muthukumar Gunasekaran, Katherine Scilla, Rena Lapidus, Brandon Cooper, Ranee Mehra, Vincenzo Adamo, Umberto Malapelle & Christian Rolfo. (2019) Liquid biopsy tracking of lung tumor evolutions over time. Expert Review of Molecular Diagnostics 19:12, pages 1099-1108.
Read now
Ernest Y. Lee & Rajan P. Kulkarni. (2019) Circulating biomarkers predictive of tumor response to cancer immunotherapy. Expert Review of Molecular Diagnostics 19:10, pages 895-904.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now

Articles from other publishers (87)

Martina Catalano, Luigi Francesco Iannone, Gabriella Nesi, Stefania Nobili, Enrico Mini & Giandomenico Roviello. (2023) Immunotherapy-related biomarkers: Confirmations and uncertainties. Critical Reviews in Oncology/Hematology 192, pages 104135.
Crossref
Wanting Hou, Yaqin Zhao & Hong Zhu. (2023) Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects. International Journal of Molecular Sciences 24:20, pages 15321.
Crossref
Qian Cui, Wentao Li, Dong Wang, Shuangcui Wang & Jianchun Yu. (2023) Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis. World Journal of Surgical Oncology 21:1.
Crossref
Xing Wang, Ziyun Qiao, Beatrice Aramini, Dong Lin, Xiaolong Li & Jiang Fan. (2023) Potential biomarkers for immunotherapy in non-small-cell lung cancer. Cancer and Metastasis Reviews 42:3, pages 661-675.
Crossref
Qian Deng, Bo Jiang, Haijiao Yan, Jun Wu & Zhenzhen Cao. (2023) Circulating tumor cells in gastric cancer: developments and clinical applications. Clinical and Experimental Medicine.
Crossref
Ying Zhou, Jinmei Zhou, Xiaopeng Hao, Haoyuan Shi, Xuejie Li, Anqi Wang, Zhiyuan Hu, Yanlian Yang, Zefei Jiang & Tao Wang. (2023) Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy. Breast Cancer Research and Treatment 200:2, pages 281-291.
Crossref
Mark Bates, Bashir M. Mohamed, Mark P. Ward, Tanya E. Kelly, Roisin O’Connor, Victoria Malone, Robert Brooks, Doug Brooks, Stavros Selemidis, Cara Martin, Sharon O’Toole & John J. O’Leary. (2023) Circulating tumour cells: The Good, the Bad and the Ugly. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:2, pages 188863.
Crossref
Qing Zhou, Xiangning Liu, Ji Li, Bing Tong, Yan Xu, Minjiang Chen, Xiaoyan Liu, Xiaoxing Gao, Yuequan Shi, Jing Zhao, Wei Zhong & Mengzhao Wang. (2023) Circulating tumor cells PD‐L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non‐small‐cell lung cancer . Thoracic Cancer 14:5, pages 470-478.
Crossref
Maria Spiliotaki, Christiana Michael Neophytou, Paris Vogazianos, Ioannis Stylianou, Gregoria Gregoriou, Andreas Ioannou Constantinou, Constantinos Deltas & Haris Charalambous. (2022) Dynamic monitoring of PD‐L1 and Ki67 in circulating tumor cells of metastatic non‐small cell lung cancer patients treated with pembrolizumab. Molecular Oncology.
Crossref
Shushan Ge, Tongtong Jia, Jihui Li, Bin Zhang, Shengming Deng & Shibiao Sang. (2022) Molecular imaging of immune checkpoints in oncology: Current and future applications. Cancer Letters 548, pages 215896.
Crossref
Junrong Li, Alain Wuethrich, Zhen Zhang, Jing Wang, Lynlee L. Lin, Andreas Behren, Yuling Wang & Matt Trau. (2022) SERS Multiplex Profiling of Melanoma Circulating Tumor Cells for Predicting the Response to Immune Checkpoint Blockade Therapy. Analytical Chemistry 94:42, pages 14573-14582.
Crossref
Zuxi Li, Meijuan Song, Shangjun Han, Chuanwei Jin & Jing Yang. (2022) The prognostic role of circulating tumor cells in gastric cancer: A meta-analysis. Frontiers in Oncology 12.
Crossref
Jiyoon Bu, Woo-jin Jeong, Roya Jafari, Luke J. Kubiatowicz, Ashita Nair, Michael J. Poellmann, Rachel S. Hong, Elizabeth W. Liu, Randall H. Owen, Piper A. Rawding, Caroline M. Hopkins, DaWon Kim, Daniel J. George, Andrew J. Armstrong, Petr Král, Andrew Z. Wang, Justine Bruce, Tian Zhang, Randall J. Kimple & Seungpyo Hong. (2022) Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis. Biosensors and Bioelectronics 213, pages 114445.
Crossref
Mengting Wang, Yaxin Liu, Bin Shao, Xiaoran Liu, Zhiyuan Hu, Chen Wang, Huiping Li, Ling Zhu, Ping Li & Yanlian Yang. (2022) HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Maria Pallozzi, Natalia Di Tommaso, Valeria Maccauro, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani & Maurizio Pompili. (2022) Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. Cancers 14:19, pages 4631.
Crossref
Yongchang Zhang, Lianxi Song, Liang Zeng, Yi Xiong, Li Liu, Chunhua Zhou, Haiyan Yang, Zhan Wang, Qing Xia, Wenjuan Jiang, Qinqin Xu & Nong Yang. (2022) Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study. BMC Cancer 22:1.
Crossref
Jinmei Zhou, Jiangling Wu, Xiaopeng Hao, Ping Li, Huiqiang Zhang, Xuexue Wu, Jiaxin Chen, Jiawei Liu, Jinyi Xiao, Shaohua Zhang, Zefei Jiang, Yanlian Yang, Zhiyuan Hu & Tao Wang. (2022) An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer. Frontiers in Oncology 12.
Crossref
Enrico Zelin, Carlo Alberto Maronese, Arianna Dri, Ludovica Toffoli, Nicola Di Meo, Gianluca Nazzaro & Iris Zalaudek. (2022) Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response. Journal of Clinical Medicine 11:12, pages 3364.
Crossref
Ying Zhou, Jinmei Zhou, Jinyi Xiao, Yuehua Wang, Hao Wang, Haoyuan Shi, Chunyan Yue, Fei Jia, Ping Li, Zhiyuan Hu, Yanlian Yang, Zefei Jiang & Tao Wang. (2022) Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy. Frontiers in Oncology 12.
Crossref
Jingting Wang, Xiao Ma, Zhongjun Ma, Yan Ma, Jing Wang & Bangwei Cao. (2022) Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers. Frontiers in Immunology 13.
Crossref
Shadma Fatima, Yafeng Ma, Azadeh Safrachi, Sana Haider, Kevin J. Spring, Fatemeh Vafaee, Kieran F. Scott, Tara L. Roberts, Therese M. Becker & Paul de Souza. (2022) Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy. Cancers 14:7, pages 1669.
Crossref
Eunice Dotse, King H. Lim, Meijun Wang, Kevin Julio Wijanarko & Kwan T. Chow. (2022) An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets. Life 12:2, pages 323.
Crossref
Mingchao Hu, Zhili Wang, Zeen Wu, Pi Ding, Renjun Pei, Qiang Wang & Chungen Xing. (2021) Circulating tumor cells in colorectal cancer in the era of precision medicine. Journal of Molecular Medicine 100:2, pages 197-213.
Crossref
Zengwei Chen, Gaoqiang Yin, Jinxiu Wei, Tongsheng Qi, Ziting Qian, Zhuyuan Wang, Shenfei Zong & Yiping Cui. (2022) Quantitative analysis of multiple breast cancer biomarkers using DNA-PAINT. Analytical Methods.
Crossref
Antonio J. Ruiz-Rodríguez, Maria P. Molina-Vallejo, Inés Aznar-Peralta, Cristina González Puga, Inés Cañas García, Encarna González, Jose A. Lorente, M. Jose Serrano & M. Carmen Garrido-Navas. (2021) Deep Phenotypic Characterisation of CTCs by Combination of Microfluidic Isolation (IsoFlux) and Imaging Flow Cytometry (ImageStream). Cancers 13:24, pages 6386.
Crossref
Huang Ao, Zhang Xin & Zhou Jian. (2021) Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma. Biomarker Research 9:1.
Crossref
Du-Bois Asante, Michael Morici, Ganendra R. K. A. Mohan, Emmanuel Acheampong, Isaac Spencer, Weitao Lin, Paula van Miert, Samantha Gibson, Aaron B. Beasley, Melanie Ziman, Leslie Calapre, Tarek M. Meniawy & Elin S. Gray. (2021) Multi-Marker Immunofluorescent Staining and PD-L1 Detection on Circulating Tumour Cells from Ovarian Cancer Patients. Cancers 13:24, pages 6225.
Crossref
Eszter Anna Janka, Tünde Várvölgyi, Zoltán Sipos, Alexandra Soós, Péter Hegyi, Szabolcs Kiss, Fanni Dembrovszky, Dezső Csupor, Patrik Kéringer, Dániel Pécsi, Margit Solymár & Gabriella Emri. (2021) Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: A Systematic Review and Meta-Analysis. Frontiers in Oncology 11.
Crossref
Mark P. Ward, Laura E. Kane, Lucy A. Norris, Bashir M. Mohamed, Tanya Kelly, Mark Bates, Andres Clarke, Nathan Brady, Cara M. Martin, Robert D. Brooks, Doug A. Brooks, Stavros Selemidis, Sean Hanniffy, Eric P. Dixon, Sharon A. O’Toole & John J. O’Leary. (2021) Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?. Molecular Cancer 20:1.
Crossref
Zhaoli Tan, Chunyan Yue, Shoujian Ji, Chuanhua Zhao, Ru Jia, Yun Zhang, Rongrui Liu, Da Li, Qian Yu, Ping Li, Zhiyuan Hu, Yanlian Yang & Jianming Xu. (2021) Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies. The Oncologist 26:12, pages e2227-e2238.
Crossref
Wantao Wu, Yihan Liu, Shan Zeng, Ying Han & Hong Shen. (2021) Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes. Journal of Hematology & Oncology 14:1.
Crossref
Yushu Ouyang, Wendao Liu, Ningning Zhang, Xiaobing Yang, Jinwei Li & Shunqin Long. (2021) Prognostic significance of programmed cell death‐ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta‐analysis. Cancer Medicine 10:20, pages 7021-7039.
Crossref
Mihaela Chivu-Economescu, Laura Necula, Lilia Matei, Denisa Dragu, Coralia Bleotu & Carmen C. Diaconu. (2021) Clinical Applications of Liquid Biopsy in Gastric Cancer. Frontiers in Medicine 8.
Crossref
Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt & Wolfgang A. Weber. (2021) Synthesis and Preclinical Evaluation of a 68 Ga-Labeled Adnectin, 68 Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression . Journal of Nuclear Medicine 62:9, pages 1228-1234.
Crossref
Filippo G. Dall'Olio, Francesco Gelsomino, Nicole Conci, Laura Marcolin, Andrea De Giglio, Giada Grilli, Francesca Sperandi, Francesca Fontana, Mario Terracciano, Benedetta Fragomeno, Nastassja Tober, Giulia Manferrari, Stefano Brocchi, Rita Golfieri, Michelangelo Fiorentino & Andrea Ardizzoni. (2021) PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Clinical Lung Cancer 22:5, pages 423-431.
Crossref
Panagiota Maravelia, Daniela Nascimento Silva, Giulia Rovesti, Michael Chrobok, Per Stål, Yong-Chen Lu & Anna Pasetto. (2021) Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy. Cancers 13:17, pages 4334.
Crossref
Emma Wrenn, Yin Huang & Kevin Cheung. (2021) Collective metastasis: coordinating the multicellular voyage. Clinical & Experimental Metastasis 38:4, pages 373-399.
Crossref
July Rodríguez, Jenny Avila, Christian Rolfo, Alejandro Ruíz-Patiño, Alessandro Russo, Luisa Ricaurte, Camila Ordóñez-Reyes, Oscar Arrieta, Zyanya Lucia Zatarain-Barrón, Gonzalo Recondo & Andrés F. Cardona. (2021) When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review. Oncology and Therapy 9:1, pages 89-110.
Crossref
Mahmoud Labib & Shana O. Kelley. (2021) Circulating tumor cell profiling for precision oncology. Molecular Oncology 15:6, pages 1622-1646.
Crossref
Antoine Vasseur, Nicolas Kiavue, François‐Clément Bidard, Jean‐Yves Pierga & Luc Cabel. (2020) Clinical utility of circulating tumor cells: an update. Molecular Oncology 15:6, pages 1647-1666.
Crossref
Mio Ikeda, Yasuhiro Koh, Shunsuke Teraoka, Koichi Sato, Jun Oyanagi, Atsushi Hayata, Nahomi Tokudome, Hiroaki Akamatsu, Yuichi Ozawa, Katsuya Endo, Masayuki Higuchi, Masanori Nakanishi, Hiroki Ueda & Nobuyuki Yamamoto. (2021) Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab. Cancers 13:10, pages 2290.
Crossref
Qiao Yang, Mingjing Chen, Jiaoyang Gu, Kai Niu, Xianlan Zhao, Linpeng Zheng, Zihan Xu, Yongxin Yu, Feng Li, Lingxin Meng, Zhengtang Chen, Wenlei Zhuo, Luping Zhang & Jianguo Sun. (2021) Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients. Frontiers in Immunology 12.
Crossref
Kathryn M. Tully, Veronica L. Nagle, Joshua A. Korsen & Jason S. Lewis. 2021. Molecular Imaging. Molecular Imaging 547 562 .
Xiao-Jiang Chen, Shu-Qiang Yuan, Jin-Ling Duan, Yong-Ming Chen, Shi Chen, Yun Wang & Yuan-Fang Li. (2020) The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis. Disease Markers 2020, pages 1-14.
Crossref
Hara Polioudaki, Anastasia Mala, Eleni Gkimprixi, Maria Papadaki, Amanda Chantziou, Maria Tzardi, Dimitris Mavroudis, Sofia Agelaki & Panayiotis Theodoropoulos. (2020) Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome. Cancers 12:12, pages 3735.
Crossref
Run-Cong Nie, Jin-Ling Duan, Yao Liang, Xiao-Jiang Chen, Yong-Ming Chen, Tian-Qi Luo, Guo-Ming Chen, Yun Wang & Yuan-Fang Li. (2020) Smoking status-based efficacy difference in anti-PD-1/PD-L1 immunotherapy: a systematic review and meta-analysis. Immunotherapy 12:18, pages 1313-1324.
Crossref
Francesc Castro-Giner & Nicola Aceto. (2020) Tracking cancer progression: from circulating tumor cells to metastasis. Genome Medicine 12:1.
Crossref
Xiaoming Zhong, Hangtian Zhang, Ying Zhu, Yuqing Liang, Zhuolin Yuan, Jiachen Li, Jing Li, Xin Li, Yifan Jia, Tian He, Jiangyuan Zhu, Yu Sun, Wengting Jiang, Hui Zhang, Cheng Wang & Zunfu Ke. (2020) Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy. Molecular Cancer 19:1.
Crossref
M. Wallesch, M. Wirth & B. Wollenberg. (2020) „Liquid biopsy“ als Schlüsselfigur in der ImmunonkologieLiquid biopsy—a possible key player in immuno-oncology. HNO 68:12, pages 899-904.
Crossref
Takahiro Okabe, Shinsaku Togo, Yuichi Fujimoto, Junko Watanabe, Issei Sumiyoshi, Akira Orimo & Kazuhisa Takahashi. (2020) Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy. Cancers 12:12, pages 3588.
Crossref
Karl Payne, Matthew Pugh, Jill Brooks, Nikolaos Batis, Graham Taylor, Paul Nankivell & Hisham Mehanna. (2020) Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 21:21, pages 8229.
Crossref
Jingjing Fan, Xiangfeng Shen, Yishu Wang, Hong-Lan Zhou, Guolong Liu, Yu-Lin Li & Zhi-Xiang Xu. (2020) Biomarkers for immune checkpoint therapy targeting programmed death 1 and programmed death ligand 1. Biomedicine & Pharmacotherapy 130, pages 110621.
Crossref
Lucrezia Raimondi, Filippo Maria Raimondi, Laura Di Benedetto, Giuseppe Cimino & Gian Paolo Spinelli. (2020) PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer. International Journal of Molecular Sciences 21:18, pages 6907.
Crossref
Po-Yu Chu, Chia-Hsun Hsieh & Min-Hsien Wu. (2020) The Combination of Immunomagnetic Bead-Based Cell Isolation and Optically Induced Dielectrophoresis (ODEP)-Based Microfluidic Device for the Negative Selection-Based Isolation of Circulating Tumor Cells (CTCs). Frontiers in Bioengineering and Biotechnology 8.
Crossref
Peng‐Fei Zhang, Yong Huang, Xiao Liang, Dan Li, Lin Jiang, Xiao Yang, Min Zhu, Hong‐Feng Gou, You‐Ling Gong, Yu‐Quan Wei, Qiu Li & Wei Wang. (2020) Enhancement of the antitumor effect of HER2‐directed CAR‐T cells through blocking epithelial‐mesenchymal transition in tumor cells. The FASEB Journal 34:8, pages 11185-11199.
Crossref
Libin Guo, Ran Wei, Yao Lin & Hang Fai Kwok. (2020) Clinical and Recent Patents Applications of PD-1/PD-L1 Targeting Immunotherapy in Cancer Treatment—Current Progress, Strategy, and Future Perspective. Frontiers in Immunology 11.
Crossref
Elisabet Cuyàs, Sara Verdura, Begoña Martin-Castillo, Tomás Alarcón, Ruth Lupu, Joaquim Bosch-Barrera & Javier A. Menendez. (2020) Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy. Cancers 12:7, pages 1757.
Crossref
Kohei Yamashita, Masaaki Iwatsuki, Jaffer A. Ajani & Hideo Baba. (2020) Programmed death ligand‐1 expression in gastrointestinal cancer: Clinical significance and future challenges. Annals of Gastroenterological Surgery 4:4, pages 369-378.
Crossref
Chaithanya Chelakkot, Jiyeon Ryu, Mi Young Kim, Jin-Soo Kim, Dohyeong Kim, Juhyun Hwang, Sung Hoon Park, Seok Bum Ko, Jeong Won Park, Moon Youn Jung, Ryong Nam Kim, Kyoung Song, Yu Jin Kim, Yoon-La Choi, Hun Seok Lee & Young Kee Shin. (2020) An Immune–Magnetophoretic Device for the Selective and Precise Enrichment of Circulating Tumor Cells from Whole Blood. Micromachines 11:6, pages 560.
Crossref
Giovanni Rossi, Alessandro Russo, Marco Tagliamento, Alessandro Tuzi, Olga Nigro, Giacomo Vallome, Claudio Sini, Massimiliano Grassi, Maria Giovanna Dal Bello, Simona Coco, Luca Longo, Lodovica Zullo, Enrica Teresa Tanda, Chiara Dellepiane, Paolo Pronzato & Carlo Genova. (2020) Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient. Cancers 12:5, pages 1125.
Crossref
Xuanyi Wang, Zixuan Chai, Yinghong Li, Fei Long, Youjin Hao, Guizhi Pan, Mingwei Liu & Bo Li. (2020) Identification of Potential Biomarkers for Anti-PD-1 Therapy in Melanoma by Weighted Correlation Network Analysis. Genes 11:4, pages 435.
Crossref
Yanyan Tang, Ping Zhang, Yumin Wang, Jinpeng Wang, Min Su, Ying Wang, Lianqing Zhou, Jumei Zhou, Wei Xiong, Zhaoyang Zeng, Yujuan Zhou, Shaolin Nie & Qianjin Liao. (2020) The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer. Frontiers in Immunology 11.
Crossref
Elaine Kilgour, Dominic G. Rothwell, Ged Brady & Caroline Dive. (2020) Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance. Cancer Cell 37:4, pages 485-495.
Crossref
Phung Thanh Huong, Sanjeev Gurshaney, Nguyen Thanh Binh, Anh Gia Pham, Huy Hoang Nguyen, Xuan Thanh Nguyen, Hai Pham-The, Phuong-Thao Tran, Khanh Truong Vu, Nhuong Xuan Duong, Claudio Pelucchi, Carlo La Vecchia, Paolo Boffetta, Hung D. Nguyen & Hung N. Luu. (2020) Emerging Role of Circulating Tumor Cells in Gastric Cancer. Cancers 12:3, pages 695.
Crossref
Meysam Yousefi, Parisa Ghaffari, Rahim Nosrati, Sadegh Dehghani, Arash Salmaninejad, Yousef Jafari Abarghan & Seyed H. Ghaffari. (2019) Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer. Cellular Oncology 43:1, pages 31-49.
Crossref
Luis Enrique Cortés-Hernández, Zahra Eslami-S, Klaus Pantel & Catherine Alix-Panabières. (2020) Molecular and Functional Characterization of Circulating Tumor Cells: From Discovery to Clinical Application. Clinical Chemistry 66:1, pages 97-104.
Crossref
Shana O Kelley & Klaus Pantel. (2020) A New Era in Liquid Biopsy: From Genotype to Phenotype. Clinical Chemistry 66:1, pages 89-96.
Crossref
Muhammed A. Bakhrebah, Mohammad Nasrullah, Wesam H. Abdulaal, Mohammed A. Hassan, Halima Siddiqui, Huda A. Al Doghaither, Ulfat M. Omar, Nawal Helmi, Mohannad M. Fallatah, Ayat B. Al-Ghafari, Mohammad Imran Khan & Hani Choudhry. (2020) High Expression of Pd-1 in Circulating Cells of Patients With Advanced Colorectal Cancer Receiving Adjuvant Therapy. Technology in Cancer Research & Treatment 19, pages 153303382096944.
Crossref
Giovanni Rossi, Alessandro Russo, Marco Tagliamento, Alessandro Tuzi, Olga Nigro, Giacomo Vollome, Claudio Sini, Massimiliano Grassi, Maria Giovanna Dal Bello, Simona Coco, Luca Longo, Lodovica Zullo, Enrica Teresa Tanda, Chiara Dellepiane, Paolo Pronzato & Carlo Genova. (2020) Präzisionsmedizin bei NSCLC im Zeitalter der Immuntherapie: Neue Biomarker zur Selektion der am besten geeigneten Therapie oder des am besten geeigneten Patienten. Kompass Pneumologie 8:6, pages 300-317.
Crossref
Sarah R. Verhoeff, Michel M. van den Heuvel, Carla M.L. van Herpen, Berber Piet, Erik H.J.G. Aarntzen & Sandra Heskamp. (2020) Programmed Cell Death-1/Ligand-1 PET Imaging. PET Clinics 15:1, pages 35-43.
Crossref
Lina Zhang, Xinyong Zhang, Yanxia Liu, Tongmei Zhang, Ziyu Wang, Meng Gu, Yilin Li, Daisy Dandan Wang, Weiying Li & Peter Ping Lin. (2020) PD-L1+ aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients. Cancer Letters 469, pages 355-366.
Crossref
Shohreh Azadi, Hamidreza Aboulkheyr Es, Arutha Kulasinghe, Pritam Bordhan & Majid Ebrahimi Warkiani. 2020. 193 235 .
Qiang Hou, Shuxian Han, Lin Yang, Shengwen Chen, Junxiu Chen, Nan Ma, Chao Wang, Jiajia Tang, Xiaogang Chen, Feng Chen, Xiang Da (Eric) Dong & LiLi Tu. (2019) The Interplay of MicroRNA-34a, LGR4, EMT-Associated Factors, and MMP2 in Regulating Uveal Melanoma Cells. Investigative Opthalmology & Visual Science 60:13, pages 4503.
Crossref
Xiu‑Yong Liao, Chao‑Yuan Liu, Jian‑Feng He, Li‑Shu Wang & Tao Zhang. (2019) Combination of checkpoint inhibitors with radiotherapy in esophageal squamous cell carcinoma treatment: A novel strategy (Review). Oncology Letters.
Crossref
David Arias Ron, Carmen M. Labandeira, María Carmen Areses Manrique, Paula Sampedro Domarco, Ihab Abdulkader, Jesús García-Mata, Christian Rolfo, Diego González-Rivas & Jose Luis Fírvida. (2019) Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report. Frontiers in Oncology 9.
Crossref
P. Hofman, S. Heeke, C. Alix-Panabières & K. Pantel. (2019) Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?. Annals of Oncology 30:9, pages 1448-1459.
Crossref
Elisabetta Rossi & Francesco Fabbri. (2019) CTCs 2020: Great Expectations or Unreasonable Dreams. Cells 8:9, pages 989.
Crossref
Kloten, Lampignano, Krahn & Schlange. (2019) Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC. Cells 8:8, pages 809.
Crossref
Kun Wang, Lin Zhou, Simin Zhao, Zule Cheng, Shihui Qiu, Yunxing Lu, Zhenhua Wu, Abdel Hady A. Abdel Wahab, Hongju Mao & Jianlong Zhao. (2019) A microfluidic platform for high-purity separating circulating tumor cells at the single-cell level. Talanta 200, pages 169-176.
Crossref
Melanie Janning, Franca Kobus, Anna Babayan, Harriet Wikman, Janna-Lisa Velthaus, Sonja Bergmann, Stefanie Schatz, Markus Falk, Lars-Arne Berger, Lisa-Marie Böttcher, Sarina Päsler, Tobias M. Gorges, Linda O’Flaherty, Claudia Hille, Simon A. Joosse, Ronald Simon, Markus Tiemann, Carsten Bokemeyer, Martin Reck, Sabine Riethdorf, Klaus Pantel & Sonja Loges. (2019) Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors. Cancers 11:6, pages 835.
Crossref
Xiangfeng Shen, Lihong Zhang, Jicheng Li, Yulin Li, Yishu Wang & Zhi-Xiang Xu. (2019) Recent Findings in the Regulation of Programmed Death Ligand 1 Expression. Frontiers in Immunology 10.
Crossref
Yariswamy Manjunath, Sathisha V. Upparahalli, Diego M. Avella, Chelsea B. Deroche, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Charles J. Smith, Guangfu Li & Jussuf T. Kaifi. (2019) PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer. Cancers 11:6, pages 806.
Crossref
Taja Lozar, Klara Gersak, Maja Cemazar, Cvetka Grasic Kuhar & Tanja Jesenko. (2019) The biology and clinical potential of circulating tumor cells. Radiology and Oncology 53:2, pages 131-147.
Crossref
Yang Wang, Tae Hyun Kim, Shamileh Fouladdel, Zhuo Zhang, Payal Soni, Angel Qin, Lili Zhao, Ebrahim Azizi, Theodore S. Lawrence, Nithya Ramnath, Kyle C. Cuneo & Sunitha Nagrath. (2019) PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer. Scientific Reports 9:1.
Crossref
Jianming Xu, Yun Zhang, Ru Jia, Chunyan Yue, Lianpeng Chang, Rongrui Liu, Gairong Zhang, Chuanhua Zhao, Yaoyue Zhang, Chunxia Chen, Yan Wang, Xin Yi, Zhiyuan Hu, Jianjun Zou & Quanren Wang. (2019) Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study. Clinical Cancer Research 25:2, pages 515-523.
Crossref
Ming Yi, Dechao Jiao, Hanxiao Xu, Qian Liu, Weiheng Zhao, Xinwei Han & Kongming Wu. (2018) Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors. Molecular Cancer 17:1.
Crossref
Kevin Leone, Cristina Poggiana & Rita Zamarchi. (2018) The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy. Diagnostics 8:3, pages 59.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.